HealthEquity, Inc. $HQY Stock Position Raised by JPMorgan Chase & Co.

JPMorgan Chase & Co. boosted its position in shares of HealthEquity, Inc. (NASDAQ:HQY) by 11.5% during the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 1,205,077 shares of the company’s stock after purchasing an additional 124,283 shares during the period. JPMorgan Chase & Co. owned 1.41% of HealthEquity worth $114,205,000 at the end of the most recent reporting period.

A number of other hedge funds also recently modified their holdings of HQY. State of New Jersey Common Pension Fund D boosted its position in shares of HealthEquity by 3.4% in the third quarter. State of New Jersey Common Pension Fund D now owns 30,066 shares of the company’s stock worth $2,849,000 after buying an additional 991 shares during the period. PNC Financial Services Group Inc. boosted its position in HealthEquity by 13.4% during the 3rd quarter. PNC Financial Services Group Inc. now owns 15,183 shares of the company’s stock worth $1,439,000 after acquiring an additional 1,793 shares during the period. HighTower Advisors LLC grew its stake in HealthEquity by 1.9% during the 3rd quarter. HighTower Advisors LLC now owns 89,133 shares of the company’s stock valued at $8,447,000 after acquiring an additional 1,621 shares in the last quarter. BTC Capital Management Inc. increased its holdings in shares of HealthEquity by 10.9% in the 3rd quarter. BTC Capital Management Inc. now owns 5,152 shares of the company’s stock valued at $488,000 after purchasing an additional 506 shares during the period. Finally, 12th Street Asset Management Company LLC lifted its position in shares of HealthEquity by 114.4% in the third quarter. 12th Street Asset Management Company LLC now owns 272,068 shares of the company’s stock worth $25,784,000 after purchasing an additional 145,151 shares in the last quarter. Hedge funds and other institutional investors own 99.55% of the company’s stock.

HealthEquity Stock Performance

NASDAQ:HQY opened at $78.89 on Monday. The firm has a market capitalization of $6.74 billion, a PE ratio of 36.19, a PEG ratio of 0.98 and a beta of 0.24. HealthEquity, Inc. has a 1 year low of $72.76 and a 1 year high of $116.65. The company has a current ratio of 4.13, a quick ratio of 4.13 and a debt-to-equity ratio of 0.46. The firm’s fifty day simple moving average is $86.55 and its 200 day simple moving average is $91.68.

HealthEquity (NASDAQ:HQY) last released its quarterly earnings results on Wednesday, December 3rd. The company reported $1.01 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.90 by $0.11. The company had revenue of $322.16 million during the quarter, compared to analysts’ expectations of $320.92 million. HealthEquity had a net margin of 14.86% and a return on equity of 12.94%. The business’s quarterly revenue was up 7.2% compared to the same quarter last year. During the same period in the prior year, the company earned $0.78 earnings per share. HealthEquity has set its FY 2026 guidance at 3.870-3.950 EPS. On average, sell-side analysts anticipate that HealthEquity, Inc. will post 2.32 EPS for the current year.

Wall Street Analyst Weigh In

A number of research analysts recently commented on the stock. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of HealthEquity in a research report on Thursday, January 22nd. BMO Capital Markets restated a “market perform” rating on shares of HealthEquity in a report on Thursday, December 4th. Raymond James Financial set a $100.00 target price on HealthEquity in a research report on Tuesday, February 17th. Barclays dropped their price objective on HealthEquity from $118.00 to $110.00 and set an “overweight” rating on the stock in a report on Wednesday. Finally, Citizens Jmp set a $122.00 target price on shares of HealthEquity in a research report on Thursday, December 4th. One research analyst has rated the stock with a Strong Buy rating, twelve have issued a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $113.87.

Insiders Place Their Bets

In related news, EVP Elimelech Rosner sold 10,959 shares of the company’s stock in a transaction on Thursday, December 18th. The shares were sold at an average price of $95.45, for a total transaction of $1,046,036.55. Following the completion of the transaction, the executive vice president directly owned 45,742 shares in the company, valued at $4,366,073.90. This represents a 19.33% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, EVP Delano Ladd sold 1,500 shares of the firm’s stock in a transaction on Friday, December 19th. The stock was sold at an average price of $94.72, for a total transaction of $142,080.00. Following the completion of the sale, the executive vice president owned 73,979 shares in the company, valued at $7,007,290.88. This represents a 1.99% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders own 1.50% of the company’s stock.

About HealthEquity

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.